Transforming the diagnostic of cardiac and pulmonary pathologies in the Emergency Room and beyond


Introducing AUSTRAL Dx

AUSTRAL Dx is a French MedTech startup created in 2021. It develops the first medical device using airborne ultrasound for the screening, diagnosis, and monitoring of cardiac and pulmonary pathologies in acute or chronic situations.

AUSTRAL Dx's technology has the potential to accelerate the paradigm shift towards early diagnosis and preventive care.

The first device developed by AUSTRAL Dx will be intended for emergency services to speed up the diagnosis of patients presenting with symptoms such as dyspnea or chest pain.